Abstract : The invention relates to the crystalline form VI of the compound of the formula (I) that is characterised by its powder X-diffraction diagram. The invention can be used in drugs.
https://hal-normandie-univ.archives-ouvertes.fr/hal-01949588
Contributor : Aurélien Lemercier <>
Submitted on : Monday, December 10, 2018 - 11:27:46 AM Last modification on : Monday, December 2, 2019 - 2:44:06 PM
Gérard Coquerel, Julie Linol, Lionel Le Pape, Jean-Pierre Lecouve. Novel crystalline form vi of agomelatine, method for preparing same and pharmaceutical compositions containing same. France, Patent n° : WO2009095555A1. 2007. ⟨hal-01949588⟩